[SCA6 presenting parkinsonism without ataxia--A case report].

A 57-year-old man was admitted to our hospital because of bradykinesia. He was diagnosed with Parkinson disease (Hoehn and Yahr grade 2) and administered levodopa at the maximum dose of 800 mg. However, his condition did not improve. While his symptoms were responsive to levodopa therapy, the sensitivity to the drug was poor. Brain MRI revealed atrophy of the upper vermis and cerebral hemispheres, and brain SPECT revealed low perfusion in both parietal lobes. I(123)-metaiodobenzylguanidine scintigraphy showed a decrease in the heart/mediastinum ratio. Striatal dopamine transporter (DAT) density was evaluated using I(123)-FP-CIT. The patient showed moderately reduced DAT density, which suggested nigrostriatal dopaminergic damage. His mother was found to have pure cerebellar ataxia without parkinsonism, and her two siblings also had celebellar type of multiple system atrophy (MSA-C) and progressive supranuclear palsy, respectively. Genetic testing revealed that the patient, his mother and the uncle with MSA-C had spinocerebellar ataxia type 6 (SCA6). SCA6 presenting parkinsonism without ataxia is very rare and important for the pathomechanism of disease.

[1]  Young Eun Kim,et al.  SCA6 presenting with young‐onset parkinsonism without ataxia , 2012, Movement disorders : official journal of the Movement Disorder Society.

[2]  Yu Kyeong Kim,et al.  The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6 , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  Sungkwon Chung,et al.  Voltage-operated Ca2+ channels regulate dopamine release from somata of dopamine neurons in the substantia nigra pars compacta. , 2008, Biochemical and biophysical research communications.

[4]  P. Witkovsky,et al.  Differential distribution of voltage‐gated calcium channels in dopaminergic neurons of the rat retina , 2006, The Journal of comparative neurology.

[5]  P. Piccini,et al.  Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6) , 2005, Movement disorders : official journal of the Movement Disorder Society.

[6]  H. Akiyama,et al.  Degeneration of the inferior olive in spinocerebellar ataxia 6 may depend on disease duration: Report of two autopsy cases and statistical analysis of autopsy cases reported to date , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.

[7]  Gyeong-Moon Kim,et al.  Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. , 2003, Archives of neurology.

[8]  R. Krüger,et al.  Extrapyramidal motor signs in degenerative ataxias. , 2000, Archives of neurology.

[9]  S. Suzuki,et al.  An autopsy case of spinocerebellar ataxia type 6 with mental symptoms of schizophrenia and dementia. , 1999, Clinical neuropathology.

[10]  S. Tsuji,et al.  Autosomal dominant cerebellar ataxia (SCA6): clinical, genetic and neuropathological study in a family , 1998, Acta Neuropathologica.

[11]  R. Krüger,et al.  Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds , 1998, Journal of neurology, neurosurgery, and psychiatry.

[12]  S. Tsuji,et al.  Spinocerebellar ataxia type 6: CAG repeat expansion in α1a voltage‐dependent calcium channel gene and clinical variations in japanese population , 1997 .

[13]  T. Takayanagi,et al.  Spinocerebellar ataxia type 6 , 1997, Neurology.

[14]  William B. Dobyns,et al.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel , 1997, Nature Genetics.